A recent phase3 trial comparing tirzepatide vs semaglutide in people living with obesity (without diabetes) reported average weight loss of 20.2% with tirzepatide vs 13.7% with semaglutide over 72 weeks
Explore Related Treatments at Lyfe Medical Wellness Patients interested in peptide therapy and healthy aging often explore additional regenerative medicine and anti-aging treatments designed to support cellular health, recovery, vitality and long-term wellness.
Insulin resistance across the spectrum of nonalcoholic fatty liver disease
Severe abdominal pain, persistent vomiting, blood in stools, or signs of dehydration require urgent medical assessment
Today, Im joined by registered dietitian Ashley Koff, author of Your Best Shot, for an evidence-informed conversation about GLP-1s in midlife
Most melanosis coli diagnoses occur during or after a colonoscopy or sigmoidoscopy for another reason